新辅助药物向免疫疗法,其次是手术切除与前期手术对肝细胞癌与大血管入侵:一个多中心研究
Xiang'an Wu1, Yuxin Wang1, Sen Wang2
1Department of Liver Surgery, Peking Union Medical College Hospital, PUMC and Chinese Academy of Medical Sciences, Dongcheng, Beijing 100730, China.
Journal of Cancer
|May 6, 2024
概括
手术前针对性免疫治疗肝细胞癌 (HCC) 和宏血管侵袭减少了复发,但增加了非瘤死亡率. 这种方法很有前途,但需要对HCC患者进行仔细的风险评估.
科学领域:
- 肝胆道手术 肝胆道手术
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 具有宏血管入侵的肝细胞癌 (HCC) 存在重大治疗挑战.
- 目前对高级HCC的治疗策略需要进一步优化.
研究的目的:
- 评估新辅助药物向免疫疗法的安全性和有效性,在手术切除之前,在患有宏血管侵袭的HCC患者中进行切除.
- 为了比较前期手术和经手术后的新辅助疗法之间的结果.
主要方法:
- 从四个医疗中心对HCC患者的大型血管侵袭的回顾性分析.
- 两个队列的比较:前期手术 (n=40) 和新辅助向免疫疗法,其次是手术 (n=22).
- 统计分析以比较术后结果,复发率和死亡率.
主要成果:
- 新辅助剂组的术后瘤增加 (72.73%对37.5%),但住院时间较短 (10对14天).
- 新辅助药向免疫治疗显著减少了3个月后 (9%vs.28.9%) 和1年后 (32.1%vs67.9%) 的复发.
- 然而,新辅助剂组的1年非瘤死亡率较高 (20.1%对2.8%).
结论:
- 术前针对性免疫疗法用于HCC与宏血管入侵降低了复发率.
- 这种新辅助方法提供了潜在的好处,但与非瘤性死亡率和慢性肝损伤风险的增加有关.
- 对于这种治疗策略来说,仔细的患者选择和风险益处评估至关重要.
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


